These above data implied that the NAD+ decline was related to susceptibility factors in the ALS, and suggested that the NAMPT-regulated NAD+ salvage synthesis pathway may be the primary explanation behind the NAD+ decline, while the protein of NMNAT that regulates the NAD+ denovo biosynthesis may increase as an adaptive response in the ALS. This evidence concerns the gene NAMPT and amyotrophic lateral sclerosis.